Mercedes Fernández Arévalo — Professor of the Pharmaceutical Technology Department at Universidad de Sevilla (Spain)

Professor of the Pharmaceutical Technology Department at Universidad de Sevilla (Spain)





Mercedes Fernández Arévalo, full Professor of the Pharmaceutical Technology Department at Universidad de Sevilla (Spain), of the Pharmacy Doctorate Program and of the Official Master’s Degree in Professional Specialization in Pharmacy, is currently the Director for Research of the University of Sevilla. She is the main researcher for the research group I+DNanomed ( Actually, she is involved, as main lines of research, in the nanotechnology applied to the development of new innovative drug administration systems, mainly for drug targeting (both passive and active targeting) and programmed release. She presents, as main interests and scientific objectives: (i) nanosystems of drug administration (API and biomolecules) with emphasis on the improvement of their bioavailability and their access to specific compartments of the organism; (ii) functionalized nanoparticles for the selective treatment of diseases; and (iii) development of new nanoteragnostic agents that simultaneously allow treatment and diagnosis by imaging techniques.


She is the principal researcher of 10 R&D&I projects of competitive public calls, having participated in a total of 17. She has experience in the transfer of research results, being responsible for 5 R&D contracts of special relevance with companies. She has published more than 80 papers in international peer reviewed (ISI) journals, more than 150 papers presented at international congresses, as well as 7 book chapters (total citations in Scopus 926; h-index 20). She has directed 11 Doctoral Theses, all with the highest qualification, 6 of them of European Doctorate or of International Mention (4 Theses in development at present), and has supervised a large number of national and international students as researcher assistant. Her doctoral students have received training supplemented by short-term research stays for 3-6 months a year at research institutions such as Univ. Austin-Texas (Prof. Peppas), Koch Institute for Integrative Cancer Research at the Institute of Massachusetts Technology (MIT) (Prof. Anderson), Univ. Goethe-Germany (Prof. Kreuter), Univ. Porto (Prof. Sarmiento), Univ. Lisboa (Prof. AJ Almeida), Univ. Cádiz (Prof. JA Micó), Univ. País Vasco (Prof. R. Hernández ), UniVr (Prof. Bentivoglio, Specialist in Neurology, Verona, Italy)…


She is co-inventor of 3 patents, last one (WO2016/128591A1) recently licensed to GBLX (USA). She is currently referee of 16 top-ranked international journals in her area of expertise.